Related Experiment Videos

Suicide Behavior Following PHQ-9 Screening Among Individuals With Substance Use Disorders

Bobbi Jo H Yarborough1, Scott P Stumbo, Brian Ahmedani

  • 1Kaiser Permanente Northwest, Center for Health Research, Portland, OR (BJHY, SPS); Henry Ford Health System, Center for Health Services Research, Detroit, MI (BA); Health Partners Institute, Minneapolis, MN (RR); Kaiser Permanente Southern California, Department of Research and Evaluation, Pasadena, CA (KC); Kaiser Permanente Colorado, Institute for Health Research, Denver, CO (JMB); Kaiser Permanente Washington Health Research Institute, Seattle, WA (GES).

Abstract

Related Concept Videos

Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
399
Borderline Personality Disorder01:25

Borderline Personality Disorder

Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
373
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
366